BioLattice Ophthalmics, Inc.
PrivateLast Round
Seed
May 5, 2026
Total Funding Raised
$2.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioLattice Ophthalmics, Inc. is a biotechnology company developing engineered cornea solutions as an alternative to donor tissue for transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLattice Ophthalmics, Inc. Comparables
Compare BioLattice Ophthalmics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CorNeat Vision | 85% | |
| LinkoCare Life Sciences | 85% | |
| Precise Bio | 84% | |
BioLattice Ophthalmics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 5, 2026 | ||||
| Seed | May 5, 2026 | ||||
| Seed Round | Mar 30, 2026 | ||||
| Grant | Aug 29, 2025 | ||||
| Grant | Aug 29, 2025 | ||||
Pre Seed | Dec 1, 2024 |
BioLattice Ophthalmics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SOSV NY and SOSV SF | Pre Seed |
| Phirst Market Ventures | Pre Seed |
| SOSV | Pre Seed |
| National Science Foundation | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 77% MoM, reaching 1K.
- Mar 30, 2026
$575K raised in Seed Round.
BioLattice Ophthalmics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioLattice Ophthalmics, Inc.'s valuation, stock price, and market status.